PAG to pick minority stake in RK Pharma
Besides secondary shares sales, transaction includes primary funding that will aid the company to expand business.
Stay updated with breaking news from Mark Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Besides secondary shares sales, transaction includes primary funding that will aid the company to expand business.
Share this article Share this article LEXINGTON, Ky., April 30, 2021 /PRNewswire/ -- CereMark Pharma, LLC (CereMark) has been notified by the University of California Los Angeles (UCLA) that a U.S. patent is awarded to UCLA for Flornaptitril, a PET scan imaging radiopharmaceutical which is licensed exclusively to CereMark. Flornaptitril binds with both tau aggregates and beta amyloid plaque to enhance PET scan imaging of these pathological proteins in the brain. CereMark clinical studies show that Flornaptitril binds with both tau aggregates and beta amyloid plaque in the brain to enhance PET...